# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-25-209064
Filing Date
2025-09-19
Accepted
2025-09-19 16:05:15
Documents
3
Period of Report
2025-10-13

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | def_14a_2025_special_mee.htm | DEF 14A | 153126
2 | GRAPHIC | img2300548_0.jpg | GRAPHIC | 458840
3 | GRAPHIC | img2300548_1.jpg | GRAPHIC | 331446
| Complete submission text file | 0001193125-25-209064.txt |  | 1242281

Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33221 | Film No.: 251326836
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)